Pen Needle Makes Insulin Injection Easier for Diabetics

Armen Hareyan's picture

Diabetes is a progressive disease that affects more than 24 million Americans, many of whom will need insulin therapy at some point in their life. However, people with diabetes face a host of barriers that stand in the way of starting an insulin regimen.

Studies suggest that as many as one-fifth to one-third of people with diabetes are hesitant or unwilling to give themselves insulin injections for reasons that include needle anxiety, a feeling of personal failure to manage their disease, and the pain and discomfort of injecting insulin. Many people with diabetes intentionally skip their insulin injections because of injection-related pain or embarrassment.

Fortunately, such barriers to insulin therapy are becoming less daunting due to improvements in patient education and communication, as well as recent innovations in the development and design of insulin injection devices and the needles these systems use. One such improvement is the recent introduction of the BD Ultra-Fine Nano – the world’s smallest pen needle.


With its short length (4mm) and thin gauge (32G), BD Nano has been shown to be as effective as longer pen needles in delivering an insulin dose to patients of all body types. The availability of BD Nano can thus be viewed as a welcome development to the more than 5 million Americans who inject insulin or GLP-1 to manage their diabetes.

“Diabetes tools have just gotten a lot better with the release of BD’s new 4 mm insulin pen needle,” said Kris Swenson, RN, CDE, and co-owner and co-founder of the Diabetes Management and Training Centers, Inc. in Phoenix, AZ. “The latest science shows that insulin injections with these new short and fine pen needles are just as effective in the delivery of insulin, and also much less frightening. This should help people get started on insulin much sooner, before long-term complications occur.”

Studies have shown that insulin injections with the BD Nano pen needle provide equivalent glucose control to that provided by longer insulin pen needles.1 It effectively delivers an insulin dose to subcutaneous issue (the layer of fat below the skin), the recommended site for insulin injections,1 while reducing the risk of injecting into muscle.

Becton, Dickinson & Company has introduced BD Nano as a tool to help people with diabetes give themselves daily insulin injections discreetly, comfortably, and with confidence. Those seeking information about BD Nano can visit

Written by Alyssa Kussin